Vancouver, BC, Canada

604-727-3014

  • LinkedIn Social Icon

©2017 BY SANOTIZE RESEARCH AND DEVELOPMENT CORP.

Our Solution - NORS

SaNOtize has been intensively evaluating nitric oxide (NO), a naturally occurring nanomolecule in the body, as a first-in-class nitrosylite drug with the potential to be used as a topical antimicrobial agent to treat a wide variety of diseases.

SaNOtize has an issued patent on a Nitric Oxide Releasing Solution (NORS).

The SaNOtize vision is to provide first line alternative NO-based antimicrobials (effective against bacteria, viruses and fungi) so that the antibiotic effective life cycle can be extended and saved for life threatening scenarios.

Moreover, this solution has significant advantages in treating multifactorial diseases.

For practical reasons, not having to use high pressure cylinders of gNO for various infections was desired. SaNOtize developed a proprietary liquid formulation to generate nitric oxide as an antimicrobial and immunomodulatory agent.